Allogene Therapeutics's Earnings Outlook

Allogene Therapeutics ALLO is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Allogene Therapeutics will report an earnings per share (EPS) of $-0.27.

Investors in Allogene Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Earnings History Snapshot

During the last quarter, the company reported an EPS beat by $0.06, leading to a 2.65% increase in the share price on the subsequent day.

Here's a look at Allogene Therapeutics's past performance and the resulting price change:

Stock Performance

Shares of Allogene Therapeutics were trading at $1.16 as of May 09. Over the last 52-week period, shares are down 59.8%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release.

To track all earnings releases for Allogene Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.